Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 50 entries
Sorted by: Best Match Show Resources per page
Learning lives across educational boundaries: Continuity and discontinuity in learning trajectories

informal learning

Erstad O.
GSID: fxWWiDkGVT4J
O Erstad - IJREE–International Journal for Research on Extended …, 2015 - elibrary.utb.de

In this article, I discuss educational boundaries as experienced by the learner across different contexts, activities and interests. Learning is understood as a trajectory beyond …

Cite
Erstad, O. (2015). Learning lives across educational boundaries: Continuity and discontinuity in learning trajectories. IJREE–International Journal for Research on Extended Education, 3(2), 7-8.
Erstad, Ola. "Learning lives across educational boundaries: Continuity and discontinuity in learning trajectories." IJREE–International Journal for Research on Extended Education 3.2 (2015): 7-8.
Copy Download .nbib Format: MLA
Autografted Electrical Burn Complicated by Cutaneous Chromoblastomycosis.

Eplasty

Erstad D, Sell N, Cauley R, Sahin Z, Goverman J.
PMID: 26557947
Eplasty. 2015 Nov 03;15:ic59. eCollection 2015.

No abstract available.

Cite
Erstad D, Sell N, Cauley R, et al. Autografted Electrical Burn Complicated by Cutaneous Chromoblastomycosis. Eplasty. 2015;15:ic59
Erstad, D., Sell, N., Cauley, R., Sahin, Z., & Goverman, J. (2015). Autografted Electrical Burn Complicated by Cutaneous Chromoblastomycosis. Eplasty, 15ic59.
Erstad, Derek, et al. "Autografted Electrical Burn Complicated by Cutaneous Chromoblastomycosis." Eplasty vol. 15 (2015): ic59.
Erstad D, Sell N, Cauley R, Sahin Z, Goverman J. Autografted Electrical Burn Complicated by Cutaneous Chromoblastomycosis. Eplasty. 2015 Nov 03;15:ic59. eCollection 2015. PMID: 26557947; PMCID: PMC4633775.
Copy Download .nbib Format: NLM
Impact of delayed initiation of erythropoietin in critically ill patients.

BMC blood disorders

Duby JJ, Erstad BL, Abarca J, Camamo JM, Huckleberry Y, Bramblett SN.
PMID: 17916251
BMC Blood Disord. 2007 Oct 04;7:1. doi: 10.1186/1471-2326-7-1.

BACKGROUND: The purpose of this study was to evaluate the impact of recombinant human erythropoietin (rHuEPO) use for anemia of critical illness at a practice site where delayed initiation is common.METHODS: Retrospective medical record review involving patients treated with...

Cite
Duby JJ, Erstad BL, Abarca J, et al. Impact of delayed initiation of erythropoietin in critically ill patients. BMC Blood Disord. 2007;7:1doi: 10.1186/1471-2326-7-1.
Duby, J. J., Erstad, B. L., Abarca, J., Camamo, J. M., Huckleberry, Y., & Bramblett, S. N. (2007). Impact of delayed initiation of erythropoietin in critically ill patients. BMC blood disorders, 71. https://doi.org/10.1186/1471-2326-7-1
Duby, Jeremiah J, et al. "Impact of delayed initiation of erythropoietin in critically ill patients." BMC blood disorders vol. 7 (2007): 1. doi: https://doi.org/10.1186/1471-2326-7-1
Duby JJ, Erstad BL, Abarca J, Camamo JM, Huckleberry Y, Bramblett SN. Impact of delayed initiation of erythropoietin in critically ill patients. BMC Blood Disord. 2007 Oct 04;7:1. doi: 10.1186/1471-2326-7-1. PMID: 17916251; PMCID: PMC2077862.
Copy Download .nbib Format: NLM
Fecal SARS-CoV-2 RNA is associated with decreased COVID-19 survival.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Das Adhikari U, Eng G, Farcasanu M, Avena LE, Choudhary MC, Triant VA, Flagg M, Schiff AE, Gomez I, Froehle LM, Diefenbach TJ, Ronsard L, Lingwood D, Lee GC, Rabi SA, Erstad D, Velmahos G, Li JZ, Hodin R, Stone JR, Honko AN, Griffiths A, Yilmaz O, Kwon DS.
PMID: 34245255
Clin Infect Dis. 2021 Jul 10; doi: 10.1093/cid/ciab623. Epub 2021 Jul 10.

The clinical significance of SARS CoV-2 RNA in stool remains uncertain. We found that extrapulmonary dissemination of infection to the gastrointestinal (GI) tract, assessed by the presence of SARS-CoV-2 RNA in stool, is associated with decreased COVID-19 survival. Measurement...

Cite
Das Adhikari U, Eng G, Farcasanu M, et al. Fecal SARS-CoV-2 RNA is associated with decreased COVID-19 survival. Clin Infect Dis. 2021;doi: 10.1093/cid/ciab623.
Das Adhikari, U., Eng, G., Farcasanu, M., Avena, L. E., Choudhary, M. C., Triant, V. A., Flagg, M., Schiff, A. E., Gomez, I., Froehle, L. M., Diefenbach, T. J., Ronsard, L., Lingwood, D., Lee, G. C., Rabi, S. A., Erstad, D., Velmahos, G., Li, J. Z., Hodin, R., Stone, J. R., Honko, A. N., Griffiths, A., Yilmaz, O., & Kwon, D. S. (2021). Fecal SARS-CoV-2 RNA is associated with decreased COVID-19 survival. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, . https://doi.org/10.1093/cid/ciab623
Das Adhikari, Upasana, et al. "Fecal SARS-CoV-2 RNA is associated with decreased COVID-19 survival." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. (2021). doi: https://doi.org/10.1093/cid/ciab623
Das Adhikari U, Eng G, Farcasanu M, Avena LE, Choudhary MC, Triant VA, Flagg M, Schiff AE, Gomez I, Froehle LM, Diefenbach TJ, Ronsard L, Lingwood D, Lee GC, Rabi SA, Erstad D, Velmahos G, Li JZ, Hodin R, Stone JR, Honko AN, Griffiths A, Yilmaz O, Kwon DS. Fecal SARS-CoV-2 RNA is associated with decreased COVID-19 survival. Clin Infect Dis. 2021 Jul 10; doi: 10.1093/cid/ciab623. Epub 2021 Jul 10. PMID: 34245255; PMCID: PMC8406863.
Copy Download .nbib Format: NLM
Hyperoncotic Albumin Reduces Net Fluid Loss Associated With Hemodialysis.

Hospital pharmacy

Buckley MS, Erstad BL, Lansburg JM, Agarwal SK.
PMID: 32214448
Hosp Pharm. 2020 Apr;55(2):130-134. doi: 10.1177/0018578719828331. Epub 2019 Feb 04.

No abstract available.

Cite
Buckley MS, Erstad BL, Lansburg JM, et al. Hyperoncotic Albumin Reduces Net Fluid Loss Associated With Hemodialysis. Hosp Pharm. 2019;55(2):130-134doi: 10.1177/0018578719828331.
Buckley, M. S., Erstad, B. L., Lansburg, J. M., & Agarwal, S. K. (2020). Hyperoncotic Albumin Reduces Net Fluid Loss Associated With Hemodialysis. Hospital pharmacy, 55(2), 130-134. https://doi.org/10.1177/0018578719828331
Buckley, Mitchell S, et al. "Hyperoncotic Albumin Reduces Net Fluid Loss Associated With Hemodialysis." Hospital pharmacy vol. 55,2 (2020): 130-134. doi: https://doi.org/10.1177/0018578719828331
Buckley MS, Erstad BL, Lansburg JM, Agarwal SK. Hyperoncotic Albumin Reduces Net Fluid Loss Associated With Hemodialysis. Hosp Pharm. 2020 Apr;55(2):130-134. doi: 10.1177/0018578719828331. Epub 2019 Feb 04. PMID: 32214448; PMCID: PMC7081489.
Copy Download .nbib Format: NLM
Initiation of Oseltamivir in Critically Ill Patients: Variations in Prescribing Practices.

The Annals of pharmacotherapy

Campbell AM, Vraney J, Oman N, Xie C, Erstad BL.
PMID: 32674586
Ann Pharmacother. 2021 Feb;55(2):265-266. doi: 10.1177/1060028020942513. Epub 2020 Jul 16.

No abstract available.

Cite
Campbell AM, Vraney J, Oman N, et al. Initiation of Oseltamivir in Critically Ill Patients: Variations in Prescribing Practices. Ann Pharmacother. 2020;55(2):265-266doi: 10.1177/1060028020942513.
Campbell, A. M., Vraney, J., Oman, N., Xie, C., & Erstad, B. L. (2021). Initiation of Oseltamivir in Critically Ill Patients: Variations in Prescribing Practices. The Annals of pharmacotherapy, 55(2), 265-266. https://doi.org/10.1177/1060028020942513
Campbell, Ashley M, et al. "Initiation of Oseltamivir in Critically Ill Patients: Variations in Prescribing Practices." The Annals of pharmacotherapy vol. 55,2 (2021): 265-266. doi: https://doi.org/10.1177/1060028020942513
Campbell AM, Vraney J, Oman N, Xie C, Erstad BL. Initiation of Oseltamivir in Critically Ill Patients: Variations in Prescribing Practices. Ann Pharmacother. 2021 Feb;55(2):265-266. doi: 10.1177/1060028020942513. Epub 2020 Jul 16. PMID: 32674586.
Copy Download .nbib Format: NLM
Beyond academic integrity.

Journal of the American Pharmacists Association : JAPhA

Erstad BL.
PMID: 32249173
J Am Pharm Assoc (2003). 2020 Sep - Oct;60(5):e20. doi: 10.1016/j.japh.2020.03.004. Epub 2020 Apr 02.

No abstract available.

Cite
Erstad BL. Beyond academic integrity. J Am Pharm Assoc (2003). 2020;60(5):e20doi: 10.1016/j.japh.2020.03.004.
Erstad, B. L. (2020). Beyond academic integrity. Journal of the American Pharmacists Association : JAPhA, 60(5), e20. https://doi.org/10.1016/j.japh.2020.03.004
Erstad, Brian L. "Beyond academic integrity." Journal of the American Pharmacists Association : JAPhA vol. 60,5 (2020): e20. doi: https://doi.org/10.1016/j.japh.2020.03.004
Erstad BL. Beyond academic integrity. J Am Pharm Assoc (2003). 2020 Sep - Oct;60(5):e20. doi: 10.1016/j.japh.2020.03.004. Epub 2020 Apr 02. PMID: 32249173.
Copy Download .nbib Format: NLM
Feedback from Digital Systems Used in Higher Education: An Inquiry into Triggered Emotions - Two Universal Design Oriented Solutions for a Better User Experience.

Studies in health technology and informatics

Saplacan D, Herstad J, Pajalic Z.
PMID: 30371503
Stud Health Technol Inform. 2018;256:421-430.

We illustrate in this paper some of the negative emotions experienced by students when interacting with digital systems in learning situations, where there is a lack of feedback, or the interaction with digital systems is faulty. The emotions are...

Cite
Saplacan D, Herstad J, Pajalic Z. Feedback from Digital Systems Used in Higher Education: An Inquiry into Triggered Emotions - Two Universal Design Oriented Solutions for a Better User Experience. Stud Health Technol Inform. 2018;256:421-430
Saplacan, D., Herstad, J., & Pajalic, Z. (2018). Feedback from Digital Systems Used in Higher Education: An Inquiry into Triggered Emotions - Two Universal Design Oriented Solutions for a Better User Experience. Studies in health technology and informatics, 256421-430.
Saplacan, Diana, et al. "Feedback from Digital Systems Used in Higher Education: An Inquiry into Triggered Emotions - Two Universal Design Oriented Solutions for a Better User Experience." Studies in health technology and informatics vol. 256 (2018): 421-430.
Saplacan D, Herstad J, Pajalic Z. Feedback from Digital Systems Used in Higher Education: An Inquiry into Triggered Emotions - Two Universal Design Oriented Solutions for a Better User Experience. Stud Health Technol Inform. 2018;256:421-430. PMID: 30371503.
Copy Download .nbib Format: NLM
Drinking, Smoking, and Morality: Do 'Drinkers and Smokers' Constitute a Stigmatised Stereotype or a Real TB Risk Factor in the Time of HIV/AIDS?.

Social indicators research

Møller V, Erstad I, Zani D.
PMID: 32214610
Soc Indic Res. 2010;98(2):217-238. doi: 10.1007/s11205-009-9546-2. Epub 2009 Nov 07.

This paper follows up an unexpected finding from a community survey that identified drinking and smoking as the most important tuberculosis (TB) risk factor, far ahead of ones commonly associated with TB such as poverty, overcrowded living conditions, and...

Cite
Møller V, Erstad I, Zani D. Drinking, Smoking, and Morality: Do 'Drinkers and Smokers' Constitute a Stigmatised Stereotype or a Real TB Risk Factor in the Time of HIV/AIDS?. Soc Indic Res. 2009;98(2):217-238doi: 10.1007/s11205-009-9546-2.
Møller, V., Erstad, I., & Zani, D. (2010). Drinking, Smoking, and Morality: Do 'Drinkers and Smokers' Constitute a Stigmatised Stereotype or a Real TB Risk Factor in the Time of HIV/AIDS?. Social indicators research, 98(2), 217-238. https://doi.org/10.1007/s11205-009-9546-2
Møller, Valerie, et al. "Drinking, Smoking, and Morality: Do 'Drinkers and Smokers' Constitute a Stigmatised Stereotype or a Real TB Risk Factor in the Time of HIV/AIDS?." Social indicators research vol. 98,2 (2010): 217-238. doi: https://doi.org/10.1007/s11205-009-9546-2
Møller V, Erstad I, Zani D. Drinking, Smoking, and Morality: Do 'Drinkers and Smokers' Constitute a Stigmatised Stereotype or a Real TB Risk Factor in the Time of HIV/AIDS?. Soc Indic Res. 2010;98(2):217-238. doi: 10.1007/s11205-009-9546-2. Epub 2009 Nov 07. PMID: 32214610; PMCID: PMC7088702.
Copy Download .nbib Format: NLM
The autotaxin-lysophosphatidic acid pathway emerges as a therapeutic target to prevent liver cancer.

Molecular & cellular oncology

Erstad DJ, Tager AM, Hoshida Y, Fuchs BC.
PMID: 28616586
Mol Cell Oncol. 2017 Mar 31;4(3):e1311827. doi: 10.1080/23723556.2017.1311827. eCollection 2017.

Using transcriptome meta-analysis, we recently identified the autotaxin (ATX)-lysophosphatidic acid (LPA) pathway as a regulator of hepatocellular carcinoma (HCC) risk in human cirrhosis patients. Pharmacological targeting of this pathway reduced fibrosis progression and HCC development in animals, identifying ATX-LPA...

Cite
Erstad DJ, Tager AM, Hoshida Y, et al. The autotaxin-lysophosphatidic acid pathway emerges as a therapeutic target to prevent liver cancer. Mol Cell Oncol. 2017;4(3):e1311827doi: 10.1080/23723556.2017.1311827.
Erstad, D. J., Tager, A. M., Hoshida, Y., & Fuchs, B. C. (2017). The autotaxin-lysophosphatidic acid pathway emerges as a therapeutic target to prevent liver cancer. Molecular & cellular oncology, 4(3), e1311827. https://doi.org/10.1080/23723556.2017.1311827
Erstad, Derek J, et al. "The autotaxin-lysophosphatidic acid pathway emerges as a therapeutic target to prevent liver cancer." Molecular & cellular oncology vol. 4,3 (2017): e1311827. doi: https://doi.org/10.1080/23723556.2017.1311827
Erstad DJ, Tager AM, Hoshida Y, Fuchs BC. The autotaxin-lysophosphatidic acid pathway emerges as a therapeutic target to prevent liver cancer. Mol Cell Oncol. 2017 Mar 31;4(3):e1311827. doi: 10.1080/23723556.2017.1311827. eCollection 2017. PMID: 28616586; PMCID: PMC5462520.
Copy Download .nbib Format: NLM
Mutational analysis of merkel cell carcinoma.

Cancers

Erstad DJ, Cusack JC.
PMID: 25329450
Cancers (Basel). 2014 Oct 17;6(4):2116-36. doi: 10.3390/cancers6042116.

Merkel cell carcinoma (MCC) is an aggressive cutaneous neuroendocrine malignancy that is associated with a poor prognosis. The pathogenesis of MCC is not well understood, and despite a recent plethora of mutational analyses, we have yet to find a...

Cite
Erstad DJ, Cusack JC. Mutational analysis of merkel cell carcinoma. Cancers (Basel). 2014;6(4):2116-36doi: 10.3390/cancers6042116.
Erstad, D. J., & Cusack, J. C. (2014). Mutational analysis of merkel cell carcinoma. Cancers, 6(4), 2116-36. https://doi.org/10.3390/cancers6042116
Erstad, Derek J, and Cusack, James C. "Mutational analysis of merkel cell carcinoma." Cancers vol. 6,4 (2014): 2116-36. doi: https://doi.org/10.3390/cancers6042116
Erstad DJ, Cusack JC. Mutational analysis of merkel cell carcinoma. Cancers (Basel). 2014 Oct 17;6(4):2116-36. doi: 10.3390/cancers6042116. PMID: 25329450; PMCID: PMC4276959.
Copy Download .nbib Format: NLM
Delays in presenting for tuberculosis treatment associated with fear of learning one is HIV-positive.

African journal of AIDS research : AJAR

Møller V, Erstad I, Cramm JM, Nieboer AP, Finkenflügel H, Radloff S, Ndoro T, Kwizera SA.
PMID: 25859617
Afr J AIDS Res. 2011 Apr;10(1):25-36. doi: 10.2989/16085906.2011.575545.

A cornerstone of tuberculosis (TB) control is early diagnosis and treatment. The first hurdle that prospective TB patients must overcome is to present at a public health clinic for treatment. The Global Plan to Stop TB addresses the new...

Cite
Møller V, Erstad I, Cramm JM, et al. Delays in presenting for tuberculosis treatment associated with fear of learning one is HIV-positive. Afr J AIDS Res. 2011;10(1):25-36doi: 10.2989/16085906.2011.575545.
Møller, V., Erstad, I., Cramm, J. M., Nieboer, A. P., Finkenflügel, H., Radloff, S., Ndoro, T., & Kwizera, S. A. (2011). Delays in presenting for tuberculosis treatment associated with fear of learning one is HIV-positive. African journal of AIDS research : AJAR, 10(1), 25-36. https://doi.org/10.2989/16085906.2011.575545
Møller, Valerie, et al. "Delays in presenting for tuberculosis treatment associated with fear of learning one is HIV-positive." African journal of AIDS research : AJAR vol. 10,1 (2011): 25-36. doi: https://doi.org/10.2989/16085906.2011.575545
Møller V, Erstad I, Cramm JM, Nieboer AP, Finkenflügel H, Radloff S, Ndoro T, Kwizera SA. Delays in presenting for tuberculosis treatment associated with fear of learning one is HIV-positive. Afr J AIDS Res. 2011 Apr;10(1):25-36. doi: 10.2989/16085906.2011.575545. PMID: 25859617.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 50 entries